Here, we report that in both normal and IPF primary human lung fibroblasts, PPAR-γ ligands potently block myofibroblast differentiation via a PPAR-γ-independent mechanism by targeting the TGFβ-induced PI3K-Akt pathway involving FAK. Here, AKT1 is linked to idiopathic pulmonary fibrosis.